Paper37608279
ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification.
Wang CW and 2 others. J Biomed Sci, 2023. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification. Papers, record 37608279. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37608279
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin-Converting Enzyme 2 | Major topic |
| COVID-19 | Major topic |
| Humans | |
| Chronic Disease | |
| Protein Processing, Post-Translational | |
| Protein Serine-Threonine Kinases | |
| Protein-Arginine N-Methyltransferases | |
| SARS-CoV-2 |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| IM-112-SP-01 | National Health Research Institutes | PubMed | ||
| NSTC-111-2320-B-400-003 | National Science and Technology Council | PubMed |
Source PubMed
References171
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10969042 | A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. | Circ Res | 2000 | https://conductscience.org/library/papers/10969042 | PubMed |
| 2 | 10924499 | A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10924499 | PubMed |
| 3 | 32759311 | Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2). | J Clin Pathol | 2021 | https://conductscience.org/library/papers/32759311 | PubMed |
| 4 | 23463883 | ACE2, angiotensin-(1–7), and Mas: the other side of the coin. | Pflugers Arch | 2013 | https://conductscience.org/library/papers/23463883 | PubMed |
| 5 | 33396184 | The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities. | Molecules | 2020 | https://conductscience.org/library/papers/33396184 | PubMed |
| 6 | 14647384 | Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. | Nature | 2003 | https://conductscience.org/library/papers/14647384 | PubMed |
| 7 | 32142651 | SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. | Cell | 2020 | https://conductscience.org/library/papers/32142651 | PubMed |
| 8 | 32863223 | Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. | Redox Biol | 2020 | https://conductscience.org/library/papers/32863223 | PubMed |
| 9 | 32715618 | The protein expression profile of ACE2 in human tissues. | Mol Syst Biol | 2020 | https://conductscience.org/library/papers/32715618 | PubMed |
| 10 | 34747367 | Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19. | JCI Insight | 2021 | https://conductscience.org/library/papers/34747367 | PubMed |
| 11 | 21208466 | Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent. | Biol Sex Differ | 2010 | https://conductscience.org/library/papers/21208466 | PubMed |
| 12 | 32432918 | Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells. | Am J Physiol Lung Cell Mol Physiol | 2020 | https://conductscience.org/library/papers/32432918 | PubMed |
| 13 | 20660625 | Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice. | Diabetes | 2010 | https://conductscience.org/library/papers/20660625 | PubMed |
| 14 | 15078862 | Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? | Hypertension | 2004 | https://conductscience.org/library/papers/15078862 | PubMed |
| 15 | 16804085 | ACE and ACE2 activity in diabetic mice. | Diabetes | 2006 | https://conductscience.org/library/papers/16804085 | PubMed |
| 16 | 17021266 | Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. | J Am Soc Nephrol | 2006 | https://conductscience.org/library/papers/17021266 | PubMed |
| 17 | 15047614 | Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. | Diabetes | 2004 | https://conductscience.org/library/papers/15047614 | PubMed |
| 18 | 18679036 | Renal ACE and ACE2 expression in early diabetic rats. | Nephron Exp Nephrol | 2008 | https://conductscience.org/library/papers/18679036 | PubMed |
| 19 | 23646149 | Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion. | PLoS One | 2013 | https://conductscience.org/library/papers/23646149 | PubMed |
| 20 | 24452639 | Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice. | Am J Physiol Renal Physiol | 2014 | https://conductscience.org/library/papers/24452639 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941771 | Metabolic Milieu and Susceptibility: The Combined Benefits of Targeting AMPK and ACE2 for Metabolic Disorders and COVID-19. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941771 | PubMed |
| 42278607 | Angiotensin-Converting Enzyme 2 Overexpression Protects Heart from Aging-Induced Injury in C57BL/6 Mice. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278607 | PubMed |
| 42272146 | ACE2 Expression and Clinical Biomarkers in COVID-19: Associations With Disease Severity. | Pulm Med | 2026 | https://conductscience.org/library/papers/42272146 | PubMed |
| 42074217 | Vascular Immune Crosstalk in COVID-19: RAAS Biomarker Signature Linking Angiotensin II to Respiratory Compromise and Soluble ACE2 to IL-13 and FGF, Revealing Therapeutic Targets. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074217 | PubMed |
| 42033495 | Inhibition of SARS-CoV-2 spike S1-ACE2 binding interaction and downregulation of ACE2 gene expression by Malaysian stingless bee honey and its bioactive compound, stilbamidine (SDC). | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42033495 | PubMed |
| 42028925 | MicroRNAs in Acute COVID-19 and Long COVID: Dysregulation, Pathogenic Roles, and Clinical Implications. | J Immunol Res | 2026 | https://conductscience.org/library/papers/42028925 | PubMed |
| 41870123 | Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/41870123 | PubMed |
| 41855156 | SAMHD1 depletion restricts SARS-CoV-2 infection by suppressing HNF1-dependent ACE2 expression in lung epithelial cells. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/41855156 | PubMed |
| 41721027 | NRF2 activators and the inhibitor of nuclear export, selinexor, restrict coronaviruses by targeting a network involving ACE2, TMPRSS2, and XPO1 through an NRF2-independent mechanism. | Commun Biol | 2026 | https://conductscience.org/library/papers/41721027 | PubMed |
| 41303587 | ACE2: Friend or Foe in Post-COVID-19 Neurodegeneration? | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303587 | PubMed |
| 41280104 | SAMHD1 promotes SARS-CoV-2 infection by enhancing HNF1-dependent ACE2 expression in lung epithelial cells. | bioRxiv | 2025 | https://conductscience.org/library/papers/41280104 | PubMed |
| 41226415 | COVID-19 Hijacking of the Host Epigenome: Mechanisms, Biomarkers and Long-Term Consequences. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226415 | PubMed |
| 40682621 | Mechanisms and Research Methods of Protein Modification in Virus Entry. | Appl Biochem Biotechnol | 2025 | https://conductscience.org/library/papers/40682621 | PubMed |
| 40658352 | Dapagliflozin ameliorates high glucose-induced epithelial-mesenchymal transition via up-regulating ACE2 mediated by EZH2 in diabetic nephropathy. | J Endocrinol Invest | 2025 | https://conductscience.org/library/papers/40658352 | PubMed |
| 40476695 | Genetic and Inflammatory Signatures Associated With Worse Prognosis in Hospitalized Patients With Severe SARS-CoV-2 Infection With and Without Diabetes. | J Med Virol | 2025 | https://conductscience.org/library/papers/40476695 | PubMed |
| 40431570 | Comparative Examination of Feline Coronavirus and Canine Coronavirus Effects on Extracellular Vesicles Acquired from A-72 Canine Fibrosarcoma Cell Line. | Vet Sci | 2025 | https://conductscience.org/library/papers/40431570 | PubMed |
| 40237797 | Pioglitazone mitigates acetic acid-induced colitis in rats via epigenetic-modulation and antioxidant mechanisms. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40237797 | PubMed |
| 40128651 | Modulation of RAAS receptors and miRNAs in COVID-19: implications for disease severity, immune response, and potential therapeutic targets. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/40128651 | PubMed |
| 39829293 | ACE2 Inhibits Dermal Regeneration Through Ang II in Tissue Expansion. | J Cosmet Dermatol | 2025 | https://conductscience.org/library/papers/39829293 | PubMed |
| 39477428 | Long-term Impacts of Long COVID: Increased Incidence of Cardiomyopathies, Joint Diseases, and Psychoanxiety Disorders. | In Vivo | 2024 | https://conductscience.org/library/papers/39477428 | PubMed |
Genes90
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37608279
GET https://conductscience.org/api/papers/v1/37608279/references?page=2